Encoded Therapeutics

workers
Biotech

Encoded lays off 29% of staff to fund Dravet gene therapy trial

Encoded is shrinking its headcount by 29% as the gene therapy biotech draws resources from its early-stage R&D toward its Dravet syndrome program.
James Waldron Feb 13, 2025 10:20am
layoffs boardroom restructuring layoff

Encoded lays off 10% of staff after back-to-back $100M+ rounds

Jun 13, 2023 3:25pm
3D medical background with DNA strand

Next-gen gene therapies for rare diseases forge ahead

Dec 14, 2020 5:28am
Encoded Therapeutics CEO Kartik Ramamoorthi and CSO Stephanie Tagliatela

Encoded bags $135M to push 'precision gene therapy' into phase 1

Jul 22, 2020 6:00am